Heteromerization of G-protein-coupled receptors. Implications for central nervous system function and dysfunction

TheScientificWorldJournal

Volumn 7, Issue SUPPL. 2, 2007, Pages 46-47

  Ferré, Sergi ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BRAIN; BRAIN DYSFUNCTION; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; EDITORIAL; FLUORESCENCE; SCIENTIST;

CENTRAL NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 37349016615     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.215     Document Type: Editorial

References (12)

1. Ferré, S., Ciruela, F., Woods, A.S., Lluis, C., and Franco, R. (2007) Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci., in press.
2. Franco, R., Casadó, V., Cortés, A., Ferrada, C., Mallol, J., Woods, A., Lluis, C., Canela, E.I., and Ferré, S. (2007) Basic concepts in G-protein-coupled receptor homo- and heterodimerization. TheScientificWorldJOURNAL 7(S2), 48-57.
3. Agnati, L.F., Ferré, S., Lluis, C., Franco, R., and Fuxe, K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509-550.
4. Zoli, M., Agnati, L.F., Hedlund, P.B., Li, X.M., Ferré, S., and Fuxe, K. (1993) Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol. Neurobiol. 7, 293-334.
5. Bouvier, M. (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2, 274-286.
6. George, S.R., and O'Dowd, B.F. (2007) A novel dopamine receptor signaling unit in brain: Heterooligomers of D1 and D2 dopamine receptors. TheScientificWorldJOURNAL 7(S2), 58-63.
7. Rashid, A.J., So, C.H., Kong, M.M., Furtak, T., El-Ghundi, M., Cheng, R., O'Dowd, B.F., and George, S.R. (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl. Acad. Sci. U. S. A. 104, 654-659.
8. Rozenfeld, R., Abul-Husn, N.S., Gomes, I., and Devi, L.A. (2007) Emerging roles of delta opioid receptors in the regulation of mu opioid receptor function. TheScientificWorldJOURNAL 7(S2), 64-73.
9. Rozenfeld, R. and Devi, L.A. (2007) Receptor heterodimerization leads to a switch in signaling: β-arrestin2-mediated ERK activation by μ-δ opioid receptor heterodimers. FASEB J., in press.
10. Ferré, S., Ciruela, F., Quiroz, C., Luján, R., Popoli, P., Cunha, R.A., Agnati, L.F., Fuxe, K., Woods, A.S., Lluis, C., and Franco, R. (2007) Adenosine receptor heteromers and their integrative role in striatal function. TheScientificWorldJOURNAL 7(S2), 74-85.
11. Ferré, S., Agnati, L.F., Ciruela, F., Lluis, C., Woods, A.S., Fuxe, K., and Franco, R. (2007) Neurotransmitter receptor heteromers and their integrative role in 'local modules': The striatal spine module. Brain Res. Rev. Epub ahead of print.
12. Jenner, P. (2003) Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease. Expert Opin. Investig. Drugs 14, 729-738.